Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older (Reprinted from MMWR, vol 61, pg 394-395, 2012)

被引：0
|
作者：
不详
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2012年 / 308卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：663 / 664
页数：2
相关论文
共 50 条
  • [31] Open-Label Trial of Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Adults ≥50 Years of Age in Mexico
    Tinoco, Juan Carlos
    Juergens, Christine
    Palacios, Guillermo M. Ruiz
    Vazquez-Narvaez, Jorge
    Enkerlin-Pauwells, Hermann Leo
    Sundaraiyer, Vani
    Pathirana, Sudam
    Kalinina, Elena
    Gruber, William C.
    Scott, Daniel A.
    Schmoele-Thoma, Beate
    CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (02) : 185 - 192
  • [32] Decreased availability of pneumococcal conjugate vaccine (Reprinted from MMWR, vol 50, pg 783-784, 2001)
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18): : 2232 - 2232
  • [33] Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
    Peterson, James T.
    Stacey, Helen L.
    MacNair, John E.
    Li, Jianing
    Hartzel, Jonathan S.
    Sterling, Tina M.
    Benner, Patrice
    Tamms, Gretchen M.
    Musey, Luwy K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) : 540 - 548
  • [34] Pneumococcus - Pneumonia 13-valent Conjugate Vaccine now available for Adults 18 years and older
    Kathmann, Wiebke
    PNEUMOLOGIE, 2015, 69 (08): : 497 - 497
  • [35] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Tomczyk, Sara
    Bennett, Nancy M.
    Stoecker, Charles
    Gierke, Ryan
    Moore, Matthew R.
    Whitney, Cynthia G.
    Hadler, Stephen
    Pilishvili, Tamara
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2014, 63 (37): : 822 - 825
  • [36] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices (vol 68, pg 1074, 2019)
    Bennett, Nancy
    Farley, Monica
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 68 (51-52): : 1195 - 1195
  • [37] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
    Matanock, Almea
    Lee, Grace
    Gierke, Ryan
    Kobayashi, Miwako
    Leidner, Andrew
    Pilishvili, Tamara
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (46): : 1069 - 1075
  • [38] A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)
    Platt, Heather L.
    Cardona, Jose F.
    Haranaka, Miwa
    Schwartz, Howard, I
    Perez, Silvia Narejos
    Dowell, Anthony
    Chang, Chih-Jen
    Dagan, Ron
    Tamms, Gretchen M.
    Sterling, Tina
    Morgan, Leslie
    Shi, Yaru
    Pedley, Alison
    Musey, Luwy K.
    Buchwald, Ulrike K.
    VACCINE, 2022, 40 (01) : 162 - 172
  • [39] Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 Through 59 Years (Reprinted from MMWR, vol 60, pg 1528, 2011)
    Harpaz, Rafael
    Hales, Craig M.
    Bialek, Stephanie R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (02): : 137 - 138
  • [40] Concomitant Administration of the Adjuvanted Recombinant Zoster Vaccine (RZV) with 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Is Safe and Does Not Interfere with Immunogenicity of Either Vaccine in Adults Aged ≥ 50 Years
    Halwe, Sandro
    Min, Ji-Young
    Mwakingwe-Omari, Agnes
    Riley, Meghan
    Molo, Lifeter-Yenwo
    Soni, Jyoti
    Girard, Ginette
    Danier, Jasur
    INTERNIST, 2022, 63 (SUPPL 3): : 343 - 343
12345